Teladoc Health (TDOC) | Stock Overview & Key Data
Teladoc Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $308.00 on February 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health TDOC | 1.40B Small-cap | -0.82% | 15.00% | 18.85% | -12.99% | -10.61% | -14.06% | -80.11% | -96.29% |
| Veeva Systems VEEV | 46.02B Large-cap | -0.80% | -0.95% | 34.02% | 29.14% | 33.27% | 49.53% | 38.37% | 12.27% |
| Ge Healthcare GEHC | 32.58B Large-cap | -0.99% | 4.93% | 28.00% | -12.82% | -4.06% | -7.06% | 31.49% | 31.49% |
| Premier PINC | 1.92B Small-cap | 0.87% | -5.03% | 15.73% | 3.59% | 2.57% | 17.15% | -40.92% | -36.78% |
| Certara CERT | 1.71B Small-cap | -1.04% | -3.14% | 25.97% | 3.45% | 6.94% | -28.00% | -50.96% | -71.30% |
| Schrodinger SDGR | 1.51B Small-cap | 3.93% | -15.90% | 19.20% | 5.36% | 5.00% | -7.90% | -35.63% | -75.62% |
Ownership & Short Interest
Teladoc Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Teladoc Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is TDOC's 52-week high and low?
In the last 52 weeks, Teladoc Health reached a high of $15.21 (on February 14, 2025) and a low of $6.35 (on April 21, 2025).
What is the market cap and P/E ratio for TDOC?
Curious about Teladoc Health's size and valuation? Its market capitalization stands at 1.40B. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.29, and the forward P/E (looking ahead) is -8.97.
Does TDOC pay dividends? If so, what's the yield?
As for dividends, Teladoc Health isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Teladoc Health's main competitors or similar companies to consider before investing?
When looking at Teladoc Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Veeva Systems VEEV | 46.02B | Healthcare | Health Information Services | 49.53% | 38.37% |
| Ge Healthcare GEHC | 32.58B | Healthcare | Health Information Services | -7.06% | 31.49% |
| Premier PINC | 1.92B | Healthcare | Health Information Services | 17.15% | -40.92% |
| Certara CERT | 1.71B | Healthcare | Health Information Services | -28.00% | -50.96% |
| Schrodinger SDGR | 1.51B | Healthcare | Health Information Services | -7.90% | -35.63% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Teladoc Health Inc.? (e.g., ROE, Debt/Equity)
To get a sense of Teladoc Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -54.49%, the Debt to Equity ratio from the most recent quarter is 111.19, and its Gross Profit Margin stands at 68.73%.
What is the recent revenue and earnings growth for TDOC?
Looking at Teladoc Health's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.60%, and quarterly earnings saw a YoY growth of -2.59%.
How much of TDOC stock is held by insiders and institutions?
Wondering who owns Teladoc Health stock? Company insiders (like executives and directors) hold about 0.98% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 74.38%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.